Actively Recruiting
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
Led by Bristol-Myers Squibb · Updated on 2026-03-17
32
Participants Needed
1
Research Sites
16 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to evaluate the effect of BMS-986278 on the cardiac repolarization in healthy participants.
CONDITIONS
Official Title
A Study to Evaluate the Effect of BMS-986278 on Cardiac Repolarization in Healthy Participants
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Female individuals not of childbearing potential and males
- Healthy as determined by medical history, physical examination, vital signs, 12-lead ECG, and clinical laboratory assessments
- Age between 18 and 55 years, inclusive
- Body mass index (BMI) between 18.0 and 32.0 kg/m2, inclusive
- Other protocol-defined inclusion/exclusion criteria apply
You will not qualify if you...
History of severe allergic reactions to study medication Currently pregnant or breastfeeding Recent participation in another clinical trial within the last 30 days Presence of uncontrolled medical conditions that could affect safety
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Worldwide Clinical Trials
San Antonio, Texas, United States, 78217
Actively Recruiting
Research Team
B
BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
CONTACT
F
First line of the email MUST contain NCT # and Site #.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
CROSSOVER
Primary Purpose
TREATMENT
Number of Arms
4
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here